BMRN vs NNVC · P/E 40, rev $1.76B vs $22.2M cap
Biomarin Pharmaceutical Inc (BMRN) versus NanoViricides Inc (NNVC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
NanoViricides Inc (NNVC) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NNVC revenue for 2026-03-31 was $0. Net income was -$6.0M. NNVC currently screens at market cap $22.2M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NNVC currently screens at market cap $22.2M.
Not investment advice. Open the BMRN and NNVC stock pages for the full models.
Not investment advice.